There is a growing market for unlicensed, compounded, or counterfeit peptides sold online, and the MHRA has issued warnings about the serious risks associated with purchasing injectable medicines from unregulated sources including contamination, incorrect or unknown dosing, and harmful impurities
But as of February 2025, the FDA declared that the semaglutide shortage was resolved
Documented side effects No published clinical trial has quantified how often GHK-Cu causes side effects in humans, at any dose or route
The pricing structure for in-clinic administration follows a similar escalation: 2.5 mg (Month 1): $255/month 5 mg (Month 2): $299/month 7.5 mg (Month 3): $399/month 10 mg (Month 4): $449/month 12.5 mg (Month 5): $499/month 15 mg (Month 6): $599/month The premium for in-clinic service ranges from $50-100 per month compared to the HomeKit option, depending on the dose level
k , SMART1-mediated Smurf1 degradation is dependent on CRBN